{"url":"https://lda.senate.gov/api/v1/filings/40a2f4be-246e-4d64-8a5c-a6dbb05de66b/","filing_uuid":"40a2f4be-246e-4d64-8a5c-a6dbb05de66b","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2019,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/40a2f4be-246e-4d64-8a5c-a6dbb05de66b/print/","filing_document_content_type":"text/html","income":"10000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Romano Romani","dt_posted":"2019-07-22T14:59:41.853000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"517 C Street, NE","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20002","registrant":{"id":30792,"url":"https://lda.senate.gov/api/v1/registrants/30792/","house_registrant_id":30115,"name":"PARRY, ROMANI, DECONCINI & SYMMS","description":"Consulting","address_1":"517 C Street NE","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20002","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ROMANO ROMANI","contact_telephone":"+1 202-547-4000","dt_updated":"2026-04-23T11:31:32.295882-04:00"},"client":{"id":136225,"url":"https://lda.senate.gov/api/v1/clients/136225/","client_id":1004811,"name":"COMPOUNDING PHARMACY, INC.","general_description":"Compounding Pharmacy","client_government_entity":false,"client_self_select":null,"state":"AR","state_display":"Arkansas","country":"US","country_display":"United States of America","ppb_state":"AR","ppb_state_display":"Arkansas","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2018-07-01"},"lobbying_activities":[{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Working to ensure the implementation of the Drug Quality and Security Act (DQSA) (Food, Drug, and Cosmetic Act (503B) is in alignment with the statutory language.  Legislation efforts include working on guidance documents issued by FDA.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":13252,"prefix":null,"prefix_display":null,"first_name":"ROMANO","nickname":null,"middle_name":null,"last_name":"ROMANI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":5895,"prefix":null,"prefix_display":null,"first_name":"STEVE","nickname":null,"middle_name":null,"last_name":"SYMMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}